Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Consolidated Statements of Cash Flows

v3.25.1
Consolidated Statements of Cash Flows
$ in Millions, $ in Millions
12 Months Ended
Mar. 31, 2025
USD ($)
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Cash Flows From Operating Activities      
Net income $ 424.0 $ 510.2 $ 512.0
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 216.2 185.0 172.6
Lease expense 32.9 26.9 23.4
Deferred income taxes 62.1 34.6 48.4
Stock-based compensation 23.0 28.2 15.7
Asbestos adjustments 137.6 151.7 37.0
Gain on sale of land 0.0 (2.0) (12.7)
Non-cash restructuring expenses 38.2 20.1 0.0
Other, net 21.1 31.6 22.5
Changes in operating assets and liabilities:      
Accounts and other receivables (28.9) (19.7) 32.1
Inventories (15.7) 3.4 (70.8)
Operating lease assets and liabilities, net (34.0) (28.0) (19.0)
Prepaid expenses and other assets (40.6) (21.5) (12.3)
Insurance receivable - Asbestos 3.9 5.6 6.2
Accounts payable and accrued liabilities 18.3 47.4 (63.2)
Claims and handling costs paid - Asbestos (114.4) (116.0) (107.9)
Income taxes payable (2.7) (4.9) 5.5
Other accrued liabilities 61.8 61.6 18.1
Net cash provided by operating activities 802.8 914.2 607.6
Cash Flows From Investing Activities      
Purchases of property, plant and equipment (422.2) (449.3) (591.3)
Proceeds from sale of property, plant and equipment 0.4 4.2 14.1
Capitalized interest (21.0) (19.5) (8.5)
Purchase of restricted investments - Asbestos (183.1) (144.2) (180.1)
Proceeds from restricted investments - Asbestos 179.2 138.3 105.7
Net cash used in investing activities (446.7) (470.5) (660.1)
Cash Flows From Financing Activities      
Shares repurchased (149.9) (271.4) (78.4)
Proceeds from term loan 0.0 300.0 0.0
Repayments of term loan (7.5) (1.9) 0.0
Proceeds from revolving credit facilities 0.0 95.0 450.0
Repayments of revolving credit facilities 0.0 (325.0) (260.0)
Debt issuance costs 0.0 (1.2) 0.0
Proceeds from issuance of shares 0.0 0.4 0.2
Repayment of finance lease obligations (1.2) (1.1) (1.5)
Dividends paid 0.0 0.0 (129.6)
Taxes paid related to net share settlement of equity awards (7.3) (4.9) (6.1)
Net cash used in financing activities (165.9) (210.1) (25.4)
Effects of exchange rate changes on cash and cash equivalents, restricted cash and restricted cash - Asbestos (0.4) (3.4) (8.4)
Net increase (decrease) in cash and cash equivalents, restricted cash and restricted cash - Asbestos 189.8 230.2 (86.3)
Cash and cash equivalents, restricted cash and restricted cash - Asbestos at beginning of period 415.8 185.6 271.9
Cash and cash equivalents, restricted cash and restricted cash - Asbestos at end of period 605.6 415.8 185.6
Non-Cash Investing and Financing Activities      
Capital expenditures incurred but not yet paid 41.3 75.0 34.7
Supplemental Disclosure of Cash Flow Activities      
Cash paid for interest 63.6 41.8 41.0
Cash payment for income taxes, net 128.1 183.1 117.1
Cash paid to AICF $ 99.2 $ 91.8 $ 109.6